Bisphosphonate-associated risk of jaw osteonecrosis?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1567, 2006-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonate-associated risk of jaw osteonecrosis?

Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Teriparatide Therapy for Bisphosphonate-Associated Osteonecrosis of the Jaw in an Elderly Japanese Woman with Severe Osteoporosis

By Iwamoto Jun

Clinical Drug Investigation, Vol. 32, Iss. 8, 2012-08 ,pp. : 547-553

Adis International

Access to resources Recommend Favorite

Risedronic acid: Bisphosphonate-associated osteonecrosis of the jaw, treated with teriparatide, in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 39-39

Adis International

Access to resources Recommend Favorite

Reduced bisphosphonate schedule may decrease jaw osteonecrosis risk

Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management

By Wimalawansa Sunil J

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 491-512

Informa Healthcare

Access to resources Recommend Favorite